Papers

Increased Oxidative Stress and NLRP3 Inflammasome Activation May Drive “Cytokine Storms” in Aging, Type 2 Diabetes, Cardiovascular Disease, Obesity and Hypertension in Persons with SARS-CoV-2 Infections

James P. Bennett, Jr. Neurodegeneration Therapeutics, Inc. Charlottesville, VA 22901 Correspondence: James P. Bennett, Jr. M.D. Ph.D. Neurodegeneration Therapeutics, Inc ...
Read More

Alzheimer’s and Parkinson’s Brain Tissues Have Reduced Expression of Genes for mtDNA OXPHOS Proteins, Mitobiogenesis Regulator PGC-1α Protein and mtRNA Stabilizing Protein LRPPRC (LRP130)

James P. Bennett, Jr. M.D., Ph.D.1 and Paula M. Keeney, B.S.11Neurodegeneration Therapeutics, Inc.Charlottesville, VA 22901Correspondence:James P. Bennett, Jr. M.D., Ph.D.Neurodegeneration ...
Read More

SARS-CoV-2 Genome Contains Mature miRNA Sequences That Can Interact Strongly With Human mRNA Genes

Running Title: SARS-CoV-2 miRNA’s and Human Genes James P. Bennett, Jr. Neurodegeneration Therapeutics, Inc. Charlottesville, Virginia Send Correspondence To: James ...
Read More

Human Microglia in Culture as a Model for Brain Neuro-inflammation

 June 18, 2019 Introduction: Activation of brain immune cells (microglia) leads to the secretion by those activated microglia of chemicals ...
Read More

Development of a Human Neural Cell Model for Developmental Neurotoxins

June 17. 2019 Introduction: Developmental neurotoxins (DNtxn) are man-made chemicals in our environment, typically used as insecticides/agricultural chemicals, which impair ...
Read More

Alzheimer’s Disease Frontal Cortex Mitochondria Show a Loss of Individual Respiratory Proteins But Preservation of Respiratory Supercomplexes

 Paula M. Kenney and James P. Bennett, Jr. Neurodegeneration Therapeutics, Inc. Charlottesville, VA Correspondence: James P. Bennett, Jr. M.D.,Ph.D. Neurodegeneration ...
Read More

RNA-Sequencing Reveals Similarities and Differences in Gene Expression in Vulnerable Brain Tissues of Alzheimer’s and Parkinson’s Diseases

James P. Bennett, Jr. and Paula M. Keeney Neurodegeneration Therapeutics, Inc. 3050A Berkmar Drive Charlottesville, VA 22901-3450 PH (434) 529-6457 ...
Read More

RNA Sequencing of Parkinson’s Ventral Midbrain to Estimate Gene Expression Reveals Marked Heterogeneity and GADD45A as a Potential Therapeutic Target

James P. Bennett, Jr.1* and Paula M. Keeney1 1Neurodegeneration Therapeutics, Inc 3050A Berkmar Drive Charlottesville, VA 22901-3450 PH: 434-529-6457 FAX: ...
Read More